Collaboration with Quantum So

RNS Number : 1344I

Fulcrum Pharma PLC

14 November 2008

 



FULCRUM PHARMA PLC 

Fulcrum Pharma and Quantum Solutions India form strategic collaboration to deliver high quality, high capacity drug safety services 

Fulcrum Pharma plc (AIM: FUL), the Professional Services company is pleased to announce a strategic collaboration with Quantum Solutions India in the field of drug safety. 

Fulcrum Pharma is committed to providing clients with expert solutions in pharmacovigilance for both pre- and post-marketed products. The collaboration brings together Fulcrum Pharma's expertise in strategic and operational pharmacovigilance and Quantum's expertise in delivering high quality ICSR and PSUR processing. 

The two companies will offer creative pharmacovigilance solutions in a cost-effective and tailored approach to new and existing clients. Quantum and Fulcrum Pharma believe that together they are positioned to deliver effective safety solutions to clients using a cost-leadership model coupled with excellence in execution and a proven track record in quality & compliance. 

Under the terms of the collaboration the companies will pool expertise and resources and establish a joint sales and marketing campaign in Europe and North America. Both companies, however, remain legally and operationally independent. 

Speaking of the newly forged strategic collaboration, Frank Armstrong, Chief Executive of Fulcrum Pharma, said: 'Together we will be in a position to meet the increasing demand for pharmacovigilance services. The collaboration with Quantum will increase our capacity to deliver key safety products to our clients and enhance the reach of our business. We look forward to working together to develop solutions for our clients.' 

Apurva Goswamy, Chief Executive of Quantum Solutions, said. 'This collaboration will provide tailored solutions to meet our customers' needs, combining the strategic and operational skills of Fulcrum Pharma with the operational expertise of Quantum Solutions. Working with Fulcrum Pharma will enable us to enhance our drug safety product offering in a way that directly benefits our clients. This is an exciting opportunity for both Quantum and Fulcrum' 

For further information, please contact: 

Fulcrum Pharma PLC

Dr Frank M. Armstrong, Chief Executive                            Tel: [phone]

Dr Phil Birch, General Manager (Europe)                          Tel: [phone]

About Fulcrum Pharma plc 

Fulcrum Pharma plc is a professional services company providing clients with expert solutions for the development of therapeutic products. Fulcrum Pharma is listed on the AIM Market of the London Stock Exchange having successfully floated in March 2000. 

About Quantum Solutions India

Quantum Solutions India is a highly-reputed quality-driven contract research organization serving the pharmaceutical industry, and specializing in drug safety. Its highly qualified, professional, English-speaking staff supported by a robust IT infrastructure ensure very high standards of service delivery.

___________________________

 

END

 

 

NRAILFEELVLVLIT